Erythropoietin as a pharmacologic alternative to blood transfusion in the surgical patient.
Goodnough
L T
LT
Case Western Reserve University School of Medicine, University Hospitals of Cleveland, OH.
D000163:Acquired Immunodeficiency Syndrome / Q000517:prevention & control / Q000635:transmission; D000328:Adult; D016063:Blood Loss, Surgical; D001803:Blood Transfusion; D001804:Blood Transfusion, Autologous; D004920:Erythropoiesis / Q000187:drug effects; D004921:Erythropoietin / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D005069:Evaluation Studies as Topic; D005260:Female; D006801:Humans; D008297:Male; D011182:Postoperative Care; D011300:Preoperative Care; D011993:Recombinant Fusion Proteins / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use; D013514:Surgical Procedures, Operative; D065227:Transfusion Reaction; D016312:Treatment Refusal
D011993:Recombinant Fusion Proteins; D004921:Erythropoietin